Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of T2 Biosystems, Inc. (TTOO) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of T2 Biosystems, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1492674.
Total stock buying since 2014: $59,813,184.
Total stock sales since 2014: $18,781,473.
Total stock option exercises since 2014: $980,850.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 55 | $133 | 378 | $0 |
| 2023 | 0 | $0 | 35,232,623 | $10,598,816 | 59,063 | $0 |
| 2022 | 73,551 | $36,328 | 63,280 | $32,070 | 971,157 | $0 |
| 2021 | 0 | $0 | 50,682 | $95,302 | 547,241 | $0 |
| 2020 | 92,508 | $59,562 | 207,551 | $176,053 | 194,910 | $0 |
| 2019 | 0 | $0 | 61,062 | $167,884 | 102,750 | $0 |
| 2018 | 4,225 | $32,321 | 209,093 | $1,280,876 | 583,336 | $473,309 |
| 2017 | 33,900 | $139,695 | 0 | $0 | 150,923 | $110,430 |
| 2016 | 0 | $0 | 27,647 | $228,078 | 27,647 | $50,445 |
| 2015 | 2,427,467 | $23,731,188 | 379,914 | $6,202,261 | 95,822 | $346,666 |
| 2014 | 3,255,315 | $35,814,090 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-09 | 0 | $0 | 55 | $133 | 0 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 378 | $0 |
| 2023-11 | 0 | $0 | 0 | $0 | 33 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 7 | $0 |
| 2023-09 | 0 | $0 | 35,215,651 | $10,588,166 | 16,400 | $0 |
| 2023-08 | 0 | $0 | 0 | $0 | 1,362 | $0 |
| 2023-03 | 0 | $0 | 239 | $114 | 333 | $0 |
| 2023-02 | 0 | $0 | 16,733 | $10,536 | 37,828 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 3,100 | $0 |
| 2022-11 | 0 | $0 | 1,292 | $2,316 | 3,333 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 732 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 448,087 | $0 |
| 2022-04 | 73,551 | $36,328 | 0 | $0 | 0 | $0 |
| 2022-03 | 0 | $0 | 0 | $0 | 38,332 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 165,719 | $0 |
| 2022-01 | 0 | $0 | 61,988 | $29,754 | 314,954 | $0 |
| 2021-08 | 0 | $0 | 0 | $0 | 68,181 | $0 |
| 2021-06 | 0 | $0 | 0 | $0 | 136,362 | $0 |
| 2021-03 | 0 | $0 | 30,872 | $54,600 | 55,834 | $0 |
| 2021-02 | 0 | $0 | 19,810 | $40,702 | 218,488 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 68,376 | $0 |
| 2020-05 | 88,308 | $57,092 | 78,056 | $48,336 | 0 | $0 |
| 2020-04 | 2,000 | $980 | 2,000 | $980 | 0 | $0 |
| 2020-03 | 2,200 | $1,490 | 2,200 | $1,490 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-13 | Elsbree David B | Sale | 55 | 2.42 | 133 |
| 2024-02-24 | Sprague John M (Chief Financial Officer) | Option Ex | 29 | .00 | 0 |
| 2024-02-24 | Gibbs Michael Terrence (General Counsel) | Option Ex | 29 | .00 | 0 |
| 2024-02-24 | Sperzel John J Iii (See Remarks) | Option Ex | 67 | .00 | 0 |
| 2024-02-20 | Giffin Brett A. (Chief Commercial Officer) | Option Ex | 13 | .00 | 0 |
| 2024-02-20 | Sprague John M (Chief Financial Officer) | Option Ex | 40 | .00 | 0 |
| 2024-02-20 | Gibbs Michael Terrence (General Counsel) | Option Ex | 40 | .00 | 0 |
| 2024-02-20 | Sperzel John J Iii (See Remarks) | Option Ex | 160 | .00 | 0 |
| 2023-11-08 | Giffin Brett A. (Chief Commercial Officer) | Option Ex | 33 | .00 | 0 |
| 2023-10-18 | Adams Laura Lee | Option Ex | 7 | .00 | 0 |
| 2023-09-26 | Crg Partners Iii (cayman) Lev Aiv I L.p. (10% Owner) | Sale | 5,392,920 | .20 | 1,083,976 |
| 2023-09-25 | Crg Partners Iii (cayman) Lev Aiv I L.p. (10% Owner) | Sale | 250,000 | .25 | 62,500 |
| 2023-09-22 | Crg Partners Iii (cayman) Lev Aiv I L.p. (10% Owner) | Sale | 5,079,344 | .26 | 1,315,550 |
| 2023-09-21 | Crg Partners Iii (cayman) Lev Aiv I L.p. (10% Owner) | Sale | 6,338,211 | .30 | 1,907,801 |
| 2023-09-20 | Crg Partners Iii (cayman) Lev Aiv I L.p. (10% Owner) | Sale | 7,753,710 | .31 | 2,411,403 |
| 2023-09-19 | Crg Partners Iii (cayman) Lev Aiv I L.p. (10% Owner) | Sale | 10,401,466 | .37 | 3,806,936 |
| 2023-09-15 | Adams Laura Lee | Option Ex | 2,300 | .00 | 0 |
| 2023-09-15 | Toft Robin | Option Ex | 2,300 | .00 | 0 |
| 2023-09-15 | Saunders Ninfa | Option Ex | 2,300 | .00 | 0 |
| 2023-09-15 | Bernard Thierry | Option Ex | 2,300 | .00 | 0 |
| 2023-09-15 | Elsbree David B | Option Ex | 2,300 | .00 | 0 |
| 2023-09-15 | Liebman Seymour | Option Ex | 2,300 | .00 | 0 |
| 2023-09-15 | Cumming John W | Option Ex | 2,600 | .00 | 0 |
| 2023-08-06 | Toft Robin | Option Ex | 454 | .00 | 0 |
| 2023-08-06 | Saunders Ninfa | Option Ex | 454 | .00 | 0 |
| 2023-08-06 | Bernard Thierry | Option Ex | 454 | .00 | 0 |
| 2023-03-28 | Gibbs Michael Terrence (General Counsel) | Sale | 239 | .48 | 114 |
| 2023-03-24 | Gibbs Michael Terrence (General Counsel) | Option Ex | 333 | .00 | 0 |
| 2023-02-28 | Sprague John M (Chief Financial Officer) | Sale | 1,148 | .59 | 677 |
| 2023-02-28 | Gibbs Michael Terrence (General Counsel) | Sale | 1,585 | .59 | 935 |
| 2023-02-28 | Sperzel John J Iii (Chairman and CEO) | Sale | 2,898 | .59 | 1,709 |
| 2023-02-24 | Sprague John M (Chief Financial Officer) | Option Ex | 2,914 | .00 | 0 |
| 2023-02-24 | Gibbs Michael Terrence (General Counsel) | Option Ex | 2,914 | .00 | 0 |
| 2023-02-24 | Sperzel John J Iii (Chairman and CEO) | Option Ex | 6,667 | .00 | 0 |
| 2023-02-22 | Giffin Brett A. (Chief Commercial Officer) | Sale | 537 | .65 | 349 |
| 2023-02-22 | Sprague John M (Chief Financial Officer) | Sale | 1,545 | .65 | 1,004 |
| 2023-02-22 | Gibbs Michael Terrence (General Counsel) | Sale | 2,145 | .65 | 1,394 |
| 2023-02-22 | Sperzel John J Iii (Chairman and CEO) | Sale | 6,875 | .65 | 4,468 |
| 2023-02-20 | Giffin Brett A. (Chief Commercial Officer) | Option Ex | 1,333 | .00 | 0 |
| 2023-02-20 | Sprague John M (Chief Financial Officer) | Option Ex | 4,000 | .00 | 0 |
| 2023-02-20 | Gibbs Michael Terrence (General Counsel) | Option Ex | 4,000 | .00 | 0 |
| 2023-02-20 | Sperzel John J Iii (Chairman and CEO) | Option Ex | 16,000 | .00 | 0 |
| 2023-01-01 | Saunders Ninfa | Option Ex | 1,550 | .00 | 0 |
| 2023-01-01 | Bernard Thierry | Option Ex | 1,550 | .00 | 0 |
| 2022-11-10 | Giffin Brett A. (Chief Commercial Officer) | Sale | 1,292 | 1.79 | 2,316 |
| 2022-11-08 | Giffin Brett A. (Chief Commercial Officer) | Option Ex | 3,333 | .00 | 0 |
| 2022-10-18 | Adams Laura Lee (Director) | Option Ex | 732 | .00 | 0 |
| 2022-06-25 | Toft Robin (Director) | Option Ex | 73,224 | .00 | 0 |
| 2022-06-25 | Saunders Ninfa (Director) | Option Ex | 73,224 | .00 | 0 |
| 2022-06-25 | Bernard Thierry (Director) | Option Ex | 73,224 | .00 | 0 |
| 2022-06-25 | Elsbree David B (Director) | Option Ex | 73,224 | .00 | 0 |
| 2022-06-25 | Liebman Seymour (Director) | Option Ex | 73,224 | .00 | 0 |
| 2022-06-25 | Cumming John W (Director) | Option Ex | 81,967 | .00 | 0 |
| 2022-04-08 | Giffin Brett A. (Chief Commercial Officer) | Buy | 10,600 | .49 | 5,183 |
| 2022-04-08 | Barclay Alec (Chief Operations Officer) | Buy | 12,951 | .50 | 6,475 |
| 2022-04-08 | Sprague John M (Chief Financial Officer) | Buy | 10,000 | .48 | 4,770 |
| 2022-04-07 | Gibbs Michael Terrence (General Counsel) | Buy | 10,000 | .49 | 4,900 |
| 2022-04-07 | Sperzel John J Iii (Chairman, CEO, and President) | Buy | 30,000 | .50 | 15,000 |
| 2022-03-24 | Gibbs Michael Terrence (General Counsel) | Option Ex | 16,666 | .00 | 0 |
| 2022-03-14 | Barclay Alec (Chief Operations Officer) | Option Ex | 21,666 | .00 | 0 |
| 2022-02-24 | Gibbs Michael Terrence (General Counsel) | Option Ex | 145,719 | .00 | 0 |
| 2022-02-21 | Sprague John M (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
| 2022-02-21 | Gibbs Michael Terrence (General Counsel) | Option Ex | 10,000 | .00 | 0 |
| 2022-01-06 | Ahuja Aparna (Chief Medical Officer) | Sale | 61,988 | .48 | 29,754 |
| 2022-01-05 | Ahuja Aparna (Chief Medical Officer) | Option Ex | 153,664 | .00 | 0 |
| 2022-01-01 | Toft Robin (Director) | Option Ex | 32,258 | .00 | 0 |
| 2022-01-01 | Saunders Ninfa (Director) | Option Ex | 32,258 | .00 | 0 |
| 2022-01-01 | Bernard Thierry (Director) | Option Ex | 32,258 | .00 | 0 |
| 2022-01-01 | Elsbree David B (Director) | Option Ex | 32,258 | .00 | 0 |
| 2022-01-01 | Liebman Seymour (Director) | Option Ex | 32,258 | .00 | 0 |
| 2021-08-06 | Toft Robin (Director) | Option Ex | 22,727 | .00 | 0 |
| 2021-08-06 | Saunders Ninfa (Director) | Option Ex | 22,727 | .00 | 0 |
| 2021-08-06 | Bernard Thierry (Director) | Option Ex | 22,727 | .00 | 0 |
| 2021-06-25 | Mcdonough John (Director) | Option Ex | 45,454 | .00 | 0 |
| 2021-06-25 | Elsbree David B (Director) | Option Ex | 45,454 | .00 | 0 |
| 2021-06-25 | Liebman Seymour (Director) | Option Ex | 45,454 | .00 | 0 |
| 2021-03-25 | Gibbs Michael Terrence (General Counsel) | Sale | 8,758 | 1.56 | 13,662 |
| 2021-03-24 | Gibbs Michael Terrence (General Counsel) | Option Ex | 16,667 | .00 | 0 |
| 2021-03-17 | Barclay Alec (Chief Operations Officer) | Sale | 12,494 | 1.86 | 23,238 |
| 2021-03-17 | Pare Anthony (Chief Commercial Officer) | Sale | 9,620 | 1.84 | 17,700 |
| 2021-03-14 | Barclay Alec (Chief Operations Officer) | Option Ex | 21,667 | .00 | 0 |
| 2021-03-14 | Pare Anthony (Chief Commercial Officer) | Option Ex | 17,500 | .00 | 0 |
| 2021-02-24 | Barclay Alec (Chief Operations Officer) | Option Ex | 168,488 | .00 | 0 |
| 2021-02-23 | Barclay Alec (Chief Operations Officer) | Sale | 7,280 | 2.06 | 14,996 |
| 2021-02-23 | Sprague John M (Chief Financial Officer) | Sale | 5,250 | 2.04 | 10,710 |
| 2021-02-23 | Gibbs Michael Terrence (General Counsel) | Sale | 7,280 | 2.06 | 14,996 |
| 2021-02-21 | Barclay Alec (Chief Operations Officer) | Option Ex | 20,000 | .00 | 0 |
| 2021-02-21 | Sprague John M (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
| 2021-02-21 | Gibbs Michael Terrence (General Counsel) | Option Ex | 10,000 | .00 | 0 |
| 2021-01-01 | Elsbree David B (Director) | Option Ex | 34,188 | .00 | 0 |
| 2021-01-01 | Liebman Seymour (Director) | Option Ex | 34,188 | .00 | 0 |
| 2020-05-20 | Jones Adrian M (Director) | Buy | 5,126 | .80 | 4,116 |
| 2020-05-20 | Goldman Sachs Group Inc (10% Owner) | Buy | 5,126 | .80 | 4,116 |
| 2020-05-19 | Jones Adrian M (Director) | Buy | 10,328 | .83 | 8,603 |
| 2020-05-19 | Jones Adrian M (Director) | Sale | 10,328 | .83 | 8,603 |
| 2020-05-19 | Goldman Sachs Group Inc (10% Owner) | Buy | 10,328 | .83 | 8,603 |
| 2020-05-19 | Goldman Sachs Group Inc (10% Owner) | Sale | 10,328 | .83 | 8,603 |
| 2020-05-12 | Jones Adrian M (Director) | Buy | 2,500 | .55 | 1,365 |
| 2020-05-12 | Jones Adrian M (Director) | Sale | 2,500 | .55 | 1,365 |
| 2020-05-12 | Goldman Sachs Group Inc (10% Owner) | Buy | 2,500 | .55 | 1,365 |
| 2020-05-12 | Goldman Sachs Group Inc (10% Owner) | Sale | 2,500 | .55 | 1,365 |
| 2020-05-06 | Jones Adrian M (Director) | Buy | 26,200 | .55 | 14,462 |
| 2020-05-06 | Jones Adrian M (Director) | Sale | 26,200 | .54 | 14,200 |
| 2020-05-06 | Goldman Sachs Group Inc (10% Owner) | Buy | 26,200 | .55 | 14,462 |
| 2020-05-06 | Goldman Sachs Group Inc (10% Owner) | Sale | 26,200 | .54 | 14,200 |
| 2020-04-09 | Jones Adrian M (Director) | Buy | 1,000 | .49 | 490 |
| 2020-04-09 | Jones Adrian M (Director) | Sale | 1,000 | .49 | 490 |
| 2020-04-09 | Goldman Sachs Group Inc (10% Owner) | Buy | 1,000 | .49 | 490 |
| 2020-04-09 | Goldman Sachs Group Inc (10% Owner) | Sale | 1,000 | .49 | 490 |
| 2020-03-25 | Jones Adrian M (Director) | Buy | 600 | .93 | 556 |
| 2020-03-25 | Jones Adrian M (Director) | Sale | 600 | .93 | 556 |
| 2020-03-25 | Goldman Sachs Group Inc (10% Owner) | Buy | 600 | .93 | 556 |
| 2020-03-25 | Goldman Sachs Group Inc (10% Owner) | Sale | 600 | .93 | 556 |
| 2020-03-24 | Jones Adrian M (Director) | Buy | 500 | .38 | 189 |
| 2020-03-24 | Jones Adrian M (Director) | Sale | 500 | .38 | 189 |
| 2020-03-24 | Goldman Sachs Group Inc (10% Owner) | Buy | 500 | .38 | 189 |
| 2020-03-24 | Goldman Sachs Group Inc (10% Owner) | Sale | 500 | .38 | 189 |
| 2020-02-24 | Barclay Alec (SVP, Operations) | Sale | 5,808 | .82 | 4,762 |
| 2020-02-24 | Sprague John M (Chief Financial Officer) | Sale | 4,166 | .82 | 3,416 |
| 2020-02-24 | Gibbs Michael Terrence (General Counsel) | Sale | 5,808 | .82 | 4,762 |
| 2020-02-24 | Lowery Thomas J. (Chief Scientific Officer) | Sale | 5,808 | .82 | 4,762 |
| 2020-02-21 | Barclay Alec (SVP, Operations) | Option Ex | 10,000 | .00 | 0 |
| 2020-02-21 | Sprague John M (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
| 2020-02-21 | Gibbs Michael Terrence (General Counsel) | Option Ex | 10,000 | .00 | 0 |
| 2020-02-21 | Lowery Thomas J. (Chief Scientific Officer) | Option Ex | 10,000 | .00 | 0 |
| 2020-02-11 | Gibbs Michael Terrence (General Counsel) | Sale | 3,200 | .77 | 2,464 |
| 2020-02-11 | Lowery Thomas J. (Chief Scientific Officer) | Sale | 3,200 | .77 | 2,464 |
| 2020-02-09 | Gibbs Michael Terrence (General Counsel) | Option Ex | 5,833 | .00 | 0 |
| 2020-02-09 | Lowery Thomas J. (Chief Scientific Officer) | Option Ex | 5,833 | .00 | 0 |
| 2020-02-03 | Gibbs Michael Terrence (General Counsel) | Sale | 3,283 | .88 | 2,889 |
| 2020-02-03 | Mcdonough John (Director) | Sale | 23,754 | .88 | 20,903 |
| 2020-02-03 | Lowery Thomas J. (Chief Scientific Officer) | Sale | 7,535 | .88 | 6,630 |
| 2020-01-23 | Mcdonough John (Director) | Sale | 57,417 | 1.15 | 66,029 |
| 2020-01-08 | Mcdonough John (Director) | Option Ex | 116,666 | .00 | 0 |
| 2020-01-03 | Elsbree David B (Director) | Sale | 5,316 | 1.16 | 6,166 |
| 2020-01-01 | Elsbree David B (Director) | Option Ex | 13,289 | .00 | 0 |
| 2020-01-01 | Liebman Seymour (Director) | Option Ex | 13,289 | .00 | 0 |
| 2019-09-11 | Barclay Alec (SVP, Operations) | Sale | 4,210 | 2.92 | 12,293 |
| 2019-09-11 | Barclay Alec (SVP, Operations) | Option Ex | 10,000 | .00 | 0 |
| 2019-06-11 | Lapidus Stanley (Director) | Sale | 9,000 | 1.44 | 12,960 |
| 2019-06-11 | Cima Michael J. (Director) | Sale | 3,240 | 1.43 | 4,633 |
| 2019-06-11 | Elsbree David B (Director) | Sale | 3,600 | 1.44 | 5,184 |
| 2019-06-11 | Cumming John W (Director) | Sale | 3,420 | 1.43 | 4,890 |
| 2019-06-08 | Lapidus Stanley (Director) | Option Ex | 9,000 | .00 | 0 |
| 2019-06-08 | Cima Michael J. (Director) | Option Ex | 9,000 | .00 | 0 |
| 2019-06-08 | Elsbree David B (Director) | Option Ex | 9,000 | .00 | 0 |
| 2019-06-08 | Liebman Seymour (Director) | Option Ex | 9,000 | .00 | 0 |
| 2019-06-08 | Cumming John W (Director) | Option Ex | 9,000 | .00 | 0 |
| 2019-02-11 | Gibbs Michael Terrence (General Counsel) | Sale | 3,005 | 3.36 | 10,096 |
| 2019-02-11 | Mcdonough John (President & CEO) | Sale | 8,134 | 3.36 | 27,330 |
Insider trading activities including stock purchases, stock sales, and option exercises of TTOO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of T2 Biosystems, Inc. (symbol TTOO, CIK number 1492674) see the Securities and Exchange Commission (SEC) website.